A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1994
12/06/1994	CA1333390C Fluorinated nucleosides and process for treating retrovirus infections therewith
12/06/1994	CA1333369C 3-propadienyl penicillin derivatives and intermediates
12/06/1994	CA1333363C Angiogenesis inhibitor comprising fumagillin
12/06/1994	CA1333362C Treatment of ocular inflammation
12/06/1994	CA1333361C Antiviral compounds
12/06/1994	CA1333360C Tocopherol-based pharmaceutical systems
12/05/1994	CA2125080A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
12/05/1994	CA2123935A1 Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease
12/04/1994	CA2125054A1 Antiviral agents
12/04/1994	CA2125021A1 Alpha-heteroaryloxymethyl ketones as interleukin-1 beta converting enzyme inhibitors
12/03/1994	CA2124748A1 Use of o-esters of l-carnitine with aromatic acids for producing pharmaceutical compositions for the treatment of dermatoses
12/01/1994	DE4418115A1 Pharmaceutical preparations contg macrolide antibiotics
12/01/1994	DE4345199A1 Use of dihydrolipoic acid
12/01/1994	DE4317646A1 Tablets containing thioctic acid and at least one basic component
11/1994
11/30/1994	EP0626388A2 14Alpha-hydroxy-4-androstene-3,6,17-trione hydrate crystal and process for producing same
11/30/1994	EP0626387A1 Nucleosides and oligonucleotides with 2'-ether groups
11/30/1994	EP0626385A1 Tetrahydropyran derivatives
11/30/1994	EP0626383A1 Palan'amine: a pharmacologically active compound from a sponge
11/30/1994	EP0626382A1 Substituted 2,4-Imidazolidinediones as antihypertensive and antiatherosclerotic agents
11/30/1994	EP0626378A1 Saccharin derivative proteolytic enzyme inhibitors
11/30/1994	EP0626376A1 Octacyclodepsipeptides having endoparasiticidal activity
11/30/1994	EP0626375A1 Octacyclodepsipeptides having endoparasiticidal activity
11/30/1994	EP0626373A1 Quinazolinone derivatives
11/30/1994	EP0626372A1 2-hydroxy-3- 1-(1H-imidazol-4-yl)alkyl benzenecarboximid-amides for the treatment of glaucoma
11/30/1994	EP0626369A1 Benzenesulfonamide derivative
11/30/1994	EP0626367A1 (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them
11/30/1994	EP0626193A1 Positively charged polyvinylidene fluoride membrane
11/30/1994	EP0626177A2 Nutrition for persons infected with human immunodeficiency virus
11/30/1994	EP0626174A2 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
11/30/1994	EP0626171A1 Oxytetracycline or doxycycline injectable solution containing PVP and N-methylpyrrolidone and/or 2-pyrrolidone
11/30/1994	EP0626168A1 Novel rafting antacid composition
11/30/1994	EP0625987A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
11/30/1994	EP0625984A1 Cephalosporin compounds
11/30/1994	EP0625983A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
11/30/1994	EP0625982A1 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents
11/30/1994	EP0625981A1 Azabicyclo compounds as calcium channel antagonists
11/30/1994	EP0625979A1 Azabricyclic compounds as calcium channel antagonists
11/30/1994	EP0625978A1 Piperazine and piperidine derivatives, and their use as antipsychotics
11/30/1994	EP0625977A1 Piperazine derivatives as 5-ht1a antagonists
11/30/1994	EP0625969A1 Arylalkoxyphenoxy-imidazoline compounds
11/30/1994	EP0625906A1 Compositions for the treatment of pylori and dermatitis
11/30/1994	EP0625905A1 Composition containing body activated fragrance for contacting the skin and method of use
11/30/1994	EP0625904A1 Bimodal molecular weight hyaluronate formulations and methods for using same
11/30/1994	EP0625903A1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
11/30/1994	EP0625902A1 Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist
11/30/1994	EP0625900A1 Compositions and processes for the sustained release of drugs.
11/30/1994	EP0625899A1 Liposomal itraconazole formulations.
11/30/1994	EP0625898A1 Liposomal piroxicam formulations.
11/30/1994	EP0574545B1 Phenyl amidines derivatives useful as platelet aggregation inhibitors
11/30/1994	EP0531410B1 (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol
11/30/1994	EP0526488B1 Benzylphosphonic acid tyrosine kinase inhibitors
11/30/1994	EP0518904B1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
11/30/1994	EP0449819B1 Structured lipid containing dairy fat
11/30/1994	EP0427799B1 Method and compounds for aica riboside delivery and for lowering blood glucose
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	EP0381750B1 Method for treating and preventing loss of bone mass
11/30/1994	EP0366765B1 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
11/30/1994	EP0329785B1 Cephalosporin derivatives
11/30/1994	CN1095721A Novel compounds
11/30/1994	CN1095720A Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
11/30/1994	CN1095719A Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds
11/30/1994	CN1095716A Novel compounds
11/30/1994	CN1095714A Phthalazinone derivatives
11/30/1994	CN1095713A Process for making compounds
11/30/1994	CN1095712A Compounds
11/30/1994	CN1095710A Enzyme Inhibitors
11/30/1994	CN1095709A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
11/30/1994	CN1095619A Health-care tortoise and soft-shelled turtle capsule and its prepn. method
11/30/1994	CN1095614A Oral liquor for treatment of psoriasis
11/30/1994	CN1095596A Skin applying solution for reducing blood-fat
11/30/1994	CN1095595A Quinolones animal-use compounded antibiotic preparation
11/30/1994	CN1095593A Agent for preventing and treating disturbances of intestinal mucous membrane
11/30/1994	CN1095592A New use
11/30/1994	CN1095591A Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor
11/30/1994	CN1095590A Treatment and prophylaxis of diseases caused by parasites or bacteria
11/30/1994	CN1095589A Method and pharmaceutical preparations for reducing the activity of cells
11/30/1994	CN1026791C The diastereoselective preparation of phosphinate esters
11/30/1994	CN1026790C 3-\|(5-methyl-2-furanyl) methyl¨-n-(4-piperidinyl)-3H-imidazo\|4,5-B¨-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
11/30/1994	CN1026789C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
11/30/1994	CN1026788C Triazole antifungal agents
11/30/1994	CN1026785C Process for the preparation of clausenamide and neoclausenamide, and of their derivatives
11/29/1994	US5369129 Preparation of topical treatment of infections caused by virus, bacteria and fungi
11/29/1994	US5369128 Method of synchronizing farrowing in swine
11/29/1994	US5369127 Treatment of glaucoma
11/29/1994	US5369120 Parkinson's disease
11/29/1994	US5369119 Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon
11/29/1994	US5369117 5-(3-formylamino-4-hydroxyphenyl)-3-(1-(4-methoxyphenyl)prop-2-yl)-oxazolidines
11/29/1994	US5369114 Angiotensin II antagonist
11/29/1994	US5369113 Certain 2,3-diphenyl-2-(1,2,4-oxadiazol-5-yl)tropanes useful as dopamide reuptake inhibitors
11/29/1994	US5369112 Method of treating cataracts caused by active oxygen
11/29/1994	US5369111 Compounds as antitumor agents or anticarcinogenic agents using vinca alkaloid dimer
11/29/1994	US5369110 Biphenylyl compounds
11/29/1994	US5369108 Potent inducers of terminal differentiation and methods of use thereof
11/29/1994	US5369105 Administering to humans
11/29/1994	US5369103 Piperazine derivatives
11/29/1994	US5369102 2-substituted alkyl-3-carboxy carbopenems as antibiotics and a method of producing them
11/29/1994	US5369101 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
11/29/1994	US5369098 Hydroxymethyl cyclobutyl purines
11/29/1994	US5369096 Glycolipid derivatives
11/29/1994	US5369030 Method of inducing cellular differentiations and altering cell phenotype using ceramide analogs

1 ... 7062 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 7078 7079 7080 7081 7082 ... 7860